Sponsor:
Cellvax Therapeutics Inc
Code:
NCT06636682
Conditions
Prostate Cancer (Adenocarcinoma)
Prostate CA
Prostate Cancers
Prostate Cancer (Post Prostatectomy)
Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
FK-PC101
Standard of Care (SOC)
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-05-01. This information was provided to ClinicalTrials.gov by Cellvax Therapeutics Inc on 2024-10-21.